GCTransplant
Advancing clinical innovation to positively impact long-term outcomes for Canadian transplant recipients
Transplantation is the optimal treatment for patients with kidney failure, but rejection causes premature graft loss in as many as 30 percent of recipients. The Genome Canada Transplant Consortium (GCTC) brings together over 22 major universities, 70+ researchers, clinical programs, provincial transplant organizations, and commercial/industry partners in Canada, with significant international collaborations. The Precision Medicine in Transplantation Cluster draws together the leading researchers from GCTC and from various UBC departments to advance expertise in laboratory, clinical and therapeutic aspects of both solid organ and stem cell transplantation.
The core goal is to develop and implement novel genomic approaches for donor-patient matching, immune monitoring, and the personalization of immunosuppression, striving for operational tolerance & durable transplant outcomes.
PTx 2022 Philip O’Connell - Opening Session of Precision Medicine in Transplantation Symposium
PTx 2022 Session 1 Karen Sherwood
PTx 2022 Session 1 Matthias Niemann
PTx 2022 Session 2 Giuseppe Orlando
PTx 2022 Session 2 John Coleman
PTx 2022 Session 3 Thomas Neville
PTx 2022 Session 4 Anne Halpin
PTx 2022 Session 4 Tania Bubela
PTx 2022 Session 5 Melina Messing
PTx 2022 Session 5 David Harriman
PTx 2022 Session 5 Xuehai Wang
PTx 2022 Session 6 Chris Blosser
PTx 2022 Session 7 Phillip Richmond
PTx 2022 Session 7 Amrit Singh
Lisa Ridgway: A Journey Unlike Any Other: Patient Engagement in Pharmacogenomics
David Sweet: HLA Matching and Immunosuppression--a personal perspective
Michael Mengel: Spatial Biology: Deciphering molecular phenotypes in allograft biopsies
Megan Levings: Inducing tolerance with regulatory T cells
Paul Keown: Clinical Trial Design
Ahmed Mostafa's presentation at Path to Tolerance Symposium
Marie Chantal Fortin: Stakeholders' perspectives on precision medicine in organ allocation
Paul Keown: Precision Medicine in Kidney Transplantation - a Pathway to Tolerance
Louisa Edwards' talk at Path to Tolerance Symposium
Using NGS And Nanopore Sequencing in The Field Of Transplantation And Immunity
Translational Diagnostics of Donor Derived Cell-Free DNA testing
Application of Machine Learning to Analyze Immune Cellular Compartments in a Pre-Transplant Cohort